× Industry Reports Services Press Release Contact us About us

APAC Compounding Pharmacies Market Size to Exceed $2.5 Bn By 2026

 Request a sample

According to the Graphical Research new growth forecast report titled “APAC Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral {Solid Preparations [Tablets, Capsules, Granules, Powder], Liquid Preparations [Solutions, Suspension, Emulsion, Syrup], Topical [Ointments, Creams, Gels, Pastes], Rectal [Suppositories, Enema], Parenteral [LVP, SVP]}, Nasal, Ophthalmic, Otic), By Application (Pediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility (Sterile, Non-sterile), By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy), Industry Analysis Report, Regional Outlook (Japan, China, India, Singapore, Australia, Taiwan, South Korea, Indonesia, Thailand)”, Estimated To Exceed USD 2.5 Billion By 2026.

Favorable regulatory scenario coupled with increasing number of local compounding pharmacies will accelerate the market growth.

Growing acceptance of customized medications will augment the APAC compounding pharmacies market growth. Personalized medicine or precision medicine is an emerging method for prevention and treatment of several disease that encompasses individual variability in genes, lifestyle and surrounding environment. Similarly, customized medicines offers better health outcomes to patients majorly among senior citizens, infants and individuals allergic to specific ingredients in commercial medicine. Therefore, surging demand for personalized medication and dosage levels further expands the market growth.

Based on product, the APAC compounding pharmacies market is segmented into nasal, topical, parenteral, ophthalmic, oral, otic and rectal. Amongst them, the oral segment held around USD 560 million in 2019. Substantial number of compounded medicines for the management of aches and pain treatment are preferred and available in capsule or tablet form escalating the segmental demand. The oral dosage medications allow pharmacists to formulate drugs according to patients’ needs such as flavored medication for children. The flavoring of the oral medicines makes them easy to consume enhancing the market growth.

Based on therapeutic area, the compounding market is segmented into pain management, hormone replacement, nutritional supplements, specialty drugs, dermatology applications and others. Amongst them, the pain management segment will witness more than 6.5% CAGR during the analysis timeframe. Rising incidences of chronic pain among adults owing to trauma and sedentary lifestyle will escalate the demand for pain management medication. Increasing geriatric population base across the countries of Japan, India and others with surged susceptibility to chronic disorders will secure the segmental growth.

On the basis of application, the compounding pharmacies market is segmented into veterinary, adult, pediatric and geriatric. The veterinary segment exhibited around 18% market share in 2019. The compounding pharmacies offer treatment for animals in case of unavailability of government-approved medications. Dosage forms of commercially available medications are permitted for use in few species but are not preferable for use in other species such as cats or other exotic animals. In this situations, compounding pharmacies provide specifically formulated drugs for such animal species creating robust segmental growth.

The APAC compounding pharmacies market, by sterility is bifurcated into non-sterile and sterile dosage forms. The non-sterile segment exhibited more than USD 1 billion market value in 2019. Surging demand for non-sterile customized medication such as pills, tablets, and liquids that are easy to administer augments the market demand. Similarly, non-sterile customized medication allows for self-administration as compared to sterile medication including injectable. Such factors will escalate the industry expansion.

On the basis of compounding type, the compounding pharmacies industry is fragmented into pharmaceutical ingredient alteration (PIA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and others. Pharmaceutical dosage alteration (PDA) exhibited around USD 300 million in 2019. Increasing need for altering drug dosage form as per patient’s need will foster the segmental progression. Similarly, allopathic drugs may cause adverse reactions among elderly patients suffering from chronic disorders that will spur the compounding pharmacies demand over the analysis timeframe.

Based on the distribution channel, the APAC compounding pharmacies market is classified into compounding pharmacies, hospital pharmacies and others. Amongst them, the compounding pharmacies segment is anticipated to experience more than 6.8% CAGR over the forecast period. The availability of compounded medication is increasing significantly in Asian countries including India, Singapore and others fostering the market growth. Rising awareness regarding the advantages of compounded medication will surge the demand for compounding pharmacies, further surging the business growth.

India compounding pharmacies market is anticipated to witness more than 17.5% market share in 2019. Large patient pool in India along with surging awareness regarding effectiveness of compounding pharmacies will show robust growth over the analysis timeframe. India will witness lucrative growth opportunities as physicians are prescribing compounded drugs that are customized as per elderly patient’s specific needs and requirements. Presence of local manufacturers developing customized medications such as Belle Sante and others escalates the country growth.

Some of the leading market players operating in the APAC compounding pharmacies market are Fresenius Kabi, Amber Compounding Pharmacy, Fresh Therapeutics, B. Braun, Clinigen Group, Athenex, Kingsway Compounding, Belle Santé Diagnostic & Therapeutic Institute, Super Pharmacy, Fagron, and Veterinary Specialty Pharmacy. These industry players are focusing on acquisition and merger to maintain strong foothold in APAC compounding pharmacies market. For instance, in November 2017, Clinigen announced the acquisition of Quantum Pharmaceutical Limited. This strategy enabled Clinigen to strengthen its presence in compounding pharmacies market.

APAC compounding pharmacies market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:

Compounding Pharmacies Market, By Therapeutic Area, 2015 - 2026 (USD Million)

  • Hormone Replacement
  • Pain Management
  • Dermatology applications
  • Specialty drugs
  • Nutritional supplements
  • Others

APAC Compounding Pharmacies Market, By Product, 2015 - 2026 (USD Million)

  • Oral
    • Solid preparations
      • Tablets
      • Capsules
      • Granules
      • Powder
      • Others
    • Liquid preparations
      • Solutions
      • Suspension
      • Emulsion
      • Syrup
      • Others
  • Topical
    • Ointments
    • Creams
    • Gels
    • Pastes
    • Others
  • Rectal
    • Suppositories
    • Enema
    • Others
  • Parenteral
    • LVP
    • SVP
  • Nasal
  • Ophthalmic
  • Otic

APAC Compounding Pharmacies Market, By Application, 2015 - 2026 (USD Million)

  • Pediatric
  • Adult
  • Geriatric
  • Veterinary

APAC Compounding Pharmacies Market, By Compounding Type, 2015 - 2026 (USD Million)

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

Compounding Pharmacies Market, By Sterility, 2015 - 2026 (USD Million)

  • Sterile
  • Non-sterile

APAC Compounding Pharmacies Market, By Distribution Channel, 2015 - 2026 (USD Million)

  • Hospital pharmacy
  • Compounding pharmacies
  • Others

The above information is provided for the following region and countries:

  • Asia Pacific
    • Japan
    • China
    • India
    • Singapore
    • Australia
    • Taiwan
    • South Korea
    • Indonesia
    • Thailand